As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Toronto Dominion Bank, CTC LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Royal Bank of Canada, Private Capital Management LLC, Man Group plc, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, Moore Capital Management LP, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cresset Asset Management LLC, Cubist Systematic Strategies LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Paloma Partners Management Co, Tudor Investment Corp ET AL, Capital Markets Trading UK LLP, CMT Capital Markets Trading GmbH, Parallax Volatility Advisers L.P., Credit Industriel ET Commercial, Cigogne Management SA, Susquehanna International Group LLP, Susquehanna Advisors Group Inc., Tradition Wealth Management LLC, HAP Trading LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, Bank of Nova Scotia, Wells Fargo & Company MN, ExodusPoint Capital Management LP, National Bank of Canada FI, JPMorgan Chase & Co., Mirae Asset Securities USA Inc., LPL Financial LLC, Simplex Trading LLC, Twin Tree Management LP, Delta Accumulation LLC, HighTower Advisors LLC, Marathon Trading Investment Management LLC, Jag Capital Management LLC, Wernau Asset Management Inc., Private Capital Management LLC, Allianz Asset Management GmbH, Wolverine Asset Management LLC, Strategic Advisors LLC, IMC Chicago LLC, XR Securities LLC, SG Americas Securities LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.